UDP-glucuronosyltransferase genetic variation in North African populations: a comparison with African and European data

References

• Alessandrini M, Asfaha S, Dodgen TM, Warnich L, Pepper MS. 2013. Cytochrome P450 pharmacogenetics in African populations. Drug Metab Rev. 45:253–275.
   PubMed Web of Science ®Google Scholar
• Angstadt AY, Berg A, Zhu J, Miller P, Hartman TJ, Lesko SM, Muscat JE, et al. 2013. The effect of copy number variation in the phase II detoxification genes UGT2B17 and UGT2B28 on colorectal cancer risk. Cancer. 119:2477–2485.
   PubMed Web of Science ®Google Scholar
• Bekada A, Arauna LR, Deba T, Calafell F, Benhamamouch S, Comas D. 2015. Genetic heterogeneity in Algerian human populations. PLoS One. 10:e0138453.
   PubMed Web of Science ®Google Scholar
• Belhassan K, Ouldim K, Sefiani AA. 2016. Genetics and genomic medicine in Morocco: the present hope can make the future bright. Mol Genet Genomic Med. 4:588–598.
   PubMed Web of Science ®Google Scholar
• Beltrame MH, Rubel MA, Tishkoff SA. 2016. Inferences of African evolutionary history from genomic data. Curr Opin Genet Dev. 41:159–166.
   PubMed Web of Science ®Google Scholar
• Cai Q, Wang Z, Zhang W, Guo X, Shang Z, Jiang N, Tian J, Niu Y. 2014. Association between glutathione S-transferases M1 and T1 gene polymorphisms and prostate cancer risk: a systematic review and meta-analysis. Tumour Biol. 35:247–256.
   PubMed Web of Science ®Google Scholar
• Che X, Yu D, Wu Z, Zhang J, Chen Y, Han Y, Wang C, Qi J. 2015. Association of genetic polymorphisms in UDP-glucuronosyltransferases 2B17 with the risk of pancreatic cancer in Chinese Han population. Clin Lab. 61:1905–1910.
   PubMed Web of Science ®Google Scholar
• Chen G, Giambrone NE, Jr., Dluzen DF, Muscat JE, Berg A, Gallagher CJ, Lazarus P. 2010. Glucuronidation genotypes and nicotine metabolic phenotypes: importance of functional UGT2B10 and UGT2B17 polymorphisms. Cancer Res. 70:7543–7552.
   PubMed Web of Science ®Google Scholar
• Cherif MH, Serraino D, Mahnane A, Laouamri S, Zaidi Z, Boukharouba H, Cherka D, et al. 2014. Time trends of cancer incidence in Setif, Algeria, 1986-2010: an observational study. BMC Cancer. 14:637
   PubMed Web of Science ®Google Scholar
• Cherni L, Frigi S, Ennafaa H, Mtiraoui N, Mahjoub T, Benammar-Elgaaied A. 2011. Human Alu insertion polymorphisms in North African populations. Hum Biol. 83:611–626.
   PubMed Web of Science ®Google Scholar
• Du Z, Jiao Y, Shi L. 2016. Association of UGT2B7 and UGT1A4 polymorphisms with serum concentration of antiepileptic drugs in children. Med Sci Monit. 22:4107–4113.
   PubMed Web of Science ®Google Scholar
• Esteban E, Rodon N, Via M, Gonzalez-Perez E, Santamaria J, Dugoujon JM, Chennawi FE, et al. 2006. Androgen receptor CAG and GGC polymorphisms in Mediterraneans: repeat dynamics and population relationships. J Hum Genet. 51:129–136.
   PubMed Web of Science ®Google Scholar
• Excoffier L, Lischer HE. 2010. Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows. Mol Ecol Resour. 10:64–67.
   Web of Science ®Google Scholar
• Fadhlaoui-Zid K, Garcia-Bertrand R, Alfonso-Sánchez MA, Zemni R, Benammar-Elgaaied A, Herrera RJ. 2015. Sousse: extreme genetic heterogeneity in North Africa. J Hum Genet. 60:41–49.
   PubMed Web of Science ®Google Scholar
• Fernández-Santander A, Novillo A, Gaibar M, Romero-Lorca A, Moral P, Sánchez-Cuenca D, Amir N, et al. 2016. Cytochrome and sulfotransferase gene variation in North African populations. Pharmacogenomics. 17:1415–1423.
   PubMed Web of Science ®Google Scholar
• Gaibar M, Novillo A, Romero-Lorca A, Esteban ME, Fernández-Santander A. 2018. Pharmacogenetics of UGT genes in North African populations. Pharmacogenomics J. 18:609–612.
   PubMed Web of Science ®Google Scholar
• González-Pérez E, Esteban E, Via M, Gayà-Vidal M, Athanasiadis G, Dugoujon JM, Luna F, et al. 2010. Population relationships in the Mediterranean revealed by autosomal genetic data (Alu and Alu/STR compound systems). Am J Phys Anthropol. 141:430–439.
   PubMed Web of Science ®Google Scholar
• Habibi M, Mirfakhraie R, Khani M, Rakhshan A, Azargashb E, Pouresmaeili F. 2017. Genetic variations in UGT2B28, UGT2B17, UGT2B15 genes and the risk of prostate cancer: a case-control study. Gene. 634:47–52.
   PubMed Web of Science ®Google Scholar
• Hakooz N, Alzubiedi S, Yousef AM, Arafat T, Dajani R, Ababneh N, Ismail S. 2012. UDP-glucuronosyltransferase 1A4 (UGT1A4) polymorphisms in a Jordanian population. Mol Biol Rep. 39:7763–7768.
   PubMedGoogle Scholar
• He X, Hesse LM, Hazarika S, Masse G, Harmatz JS, Greenblatt DJ, Court MH. 2009. Evidence for oxazepam as an in vivo probe of UGT2B15: oxazepam clearance is reduced by UGT2B15 D85Y polymorphism but unaffected by UGT2B17 deletion. Br J Clin Pharmacol. 68:721–730.
   PubMed Web of Science ®Google Scholar
• Henn BM, Botigué LR, Gravel S, Wang W, Brisbin A, Byrnes JK, Fadhlaoui-Zid K, et al. 2012. Genomic ancestry of North Africans supports back-to-Africa migrations. PLoS Genet. 8:e1002397.
   PubMed Web of Science ®Google Scholar
• http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx. International Agency for Research on Cancer. World Health Organization. GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012. All cancers (excluding non-melanoma skin cancer) [retrieved 7 December 2017].
   Google Scholar
• Ishimaru S, Yuza Y, Kaneko T, Urashima M. 2017. Effect of UGT2B17 deletion polymorphism on prognosis in pediatric cancer. Pediatr Int. 59:427–431.
   PubMed Web of Science ®Google Scholar
• Jombart T. 2008. Adegenet: a R package for the multivariate analysis of genetic markers. Bioinformatics. 24:1403–1405.
   PubMed Web of Science ®Google Scholar
• Lim HS, Ju Lee H, Seok Lee K, Sook Lee E, Jang IJ, Ro J. 2007. Clinical implications of CYP2D6 genotypes predictive of tamoxifen pharmacokinetics in metastatic breast cancer. J Clin Oncol. 25:3837–3845.
   PubMed Web of Science ®Google Scholar
• MacLeod SL, Nowell S, Plaxco J, Lang NP. 2000. An allele-specific polymerase chain reaction method for the determination of the D85Y polymorphism in the human UDPGlucuronosyltransferase 2B15 gene in a case-control study of prostate cancer. Ann Surg Oncol. 7:777–782.
   PubMed Web of Science ®Google Scholar
• Mafune A, Hama T, Suda T, Suzuki Y, Ikegami M, Sakanashi C, Imai S, et al. 2015. Homozygous deletions of UGT2B17 modifies effects of smoking on TP53-mutations and relapse of head and neck carcinoma. BMC Cancer. 15:205.
   PubMed Web of Science ®Google Scholar
• Novillo A, Romero-Lorca A, Gaibar M, Rubio M, Fernández-Santander A. 2017. Tamoxifen metabolism in breast cancer treatment: taking the focus off the CYP2D6 gene. Pharmacogenomics J. 17:109–111.
   PubMed Web of Science ®Google Scholar
• Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, Maller J, et al. 2007. PLINK: a toolset for whole-genome association and population-based linkage analysis. Am J Hum Genet. 81:559–575.
   PubMed Web of Science ®Google Scholar
• Pybus M, Dall’Olio GM, Luisi P, Uzkudun M, Carreño-Torres A, Pavlidis P, Laayouni H, et al. 2014. 1000 Genomes Selection Browser 1.0: a genome browser dedicated to signatures of natural selection in modern humans. Nucleic Acids Res. 42:D903–D909.
   PubMed Web of Science ®Google Scholar
• Romero-Lorca A, Novillo A, Gaibar M, Bandrés F, Fernández-Santander A. 2015. Impacts of the glucuronidase genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on tamoxifen metabolism in breast cancer patients. PLoS One. 10:e0132269.
   PubMed Web of Science ®Google Scholar
• Sai K, Saito Y. 2011. Ethnic differences in the metabolism, toxicology and efficacy of three anticancer drugs. Expert Opin Drug Metab Toxicol. 7:967–988.
   PubMed Web of Science ®Google Scholar
• Vidal AC, Tucker C, Schildkraut JM, Richardson RM, McPhail M, Freedland SJ, Hoyo C, Grant DJ. 2013. Novel associations of UDP-glucuronosyltransferase 2B gene variants with prostate cancer risk in a multiethnic study. BMC Cancer. 13:556
   PubMed Web of Science ®Google Scholar
• Xue Y, Sun D, Daly A, Yang F, Zhou X, Zhao M, Huang N, et al. 2008. Adaptive evolution of UGT2B17 copy-number variation. Am J Hum Genet. 83:337–346.
   PubMed Web of Science ®Google Scholar
• Yang TL, Chen XD, Guo Y, Lei SF, Wang JT, Zhou Q, Pan F, et al. 2008. Genome-wide copy-number-variation study identified a susceptibility gene, UGT2B17, for osteoporosis. Am J Hum Genet. 83:663–674.
   PubMed Web of Science ®Google Scholar
• Zanetti R, Tazi MA, Rosso S. 2010. New data tells us more about cancer incidence in North Africa. Eur J Cancer. 46:462–466.
   PubMed Web of Science ®Google Scholar
• Zhong X, Feng J, Xiao Y, Wang P, Fan Q, Wu R, Hu W, Huang C. 2017. Uridine diphosphate-glucuronosyltransferase 2B15 D85Y gene polymorphism is associated with lower prostate cancer risk: a systematic review and meta-analysis. Oncotarget. 8:52837–52845.
   PubMedGoogle Scholar
• Zhu AZ, Cox LS, Ahluwalia JS, Renner CC, Hatsukami DK, Benowitz NL, Tyndale RF. 2015. Genetic and phenotypic variation in UGT2B17, a testosterone-metabolizing enzyme, is associated with BMI in males. Pharmacogenet Genomics. 25:263–269.
   PubMed Web of Science ®Google Scholar